PrivateAI, a decentralized AI protocol focused on accelerating breakthroughs in life extension, has secured a successful strategic investment round and launched its native token, PGPT, for public trading. This exciting development marks a significant step forward in leveraging artificial intelligence for the betterment of humanity.
Investment and Token Launch Fuel Innovation
The strategic investment round attracted prominent figures in the blockchain and AI space, including Charlie Hu of Bitlayer, DAO Maker, and former executives from Fantom, Filecoin, Dogecoin, and Syscoin. This strong backing reflects confidence in PrivateAI’s mission and its potential to revolutionize the longevity research landscape.
Following the investment round, PGPT debuted on the Bitget cryptocurrency exchange, experiencing a remarkable 500% surge in its first 24 hours. This enthusiastic market response highlights the growing interest in projects that bridge the gap between AI and real-world applications, particularly in the pursuit of healthier and longer lives.
AI-Powered Platform to Unlock Scientific Discoveries
PrivateAI is pioneering the development of the world’s first domain-specific Large Language Model (LLM) specifically designed for the longevity industry. This AI platform leverages knowledge graphs, a unique data structuring method, to process and organize scientific research data in a way that fosters improved machine learning capabilities.
The platform offers several key advantages:
- Monetization Opportunities for Data Owners: Researchers and institutions can upload valuable longevity-related datasets and earn PGPT tokens for their contributions. This incentivizes knowledge sharing and fuels the platform’s data pool.
- Access to a Collective Scientific Mind: Companies and researchers can tap into a vast pool of scientific knowledge curated by the platform’s user base. This fosters collaboration and accelerates scientific progress.
- AI-powered Drug Discovery and Personalized Medicine: PrivateAI’s platform empowers researchers to leverage AI for tasks such as drug discovery and personalized medicine, ultimately leading to more effective interventions for age-related conditions.
The Dream of Longevity Within Reach
PrivateAI’s ultimate goal, as envisioned by co-founder Angel Versetti, is to harness the power of AI to unlock breakthroughs that extend human lifespans, potentially even indefinitely. This ambitious pursuit aligns with the long-term aspirations of space exploration and colonizing other planets.
Versetti’s Statement Reflects Optimism
Following the launch, Angel Versetti expressed his enthusiasm about the project’s potential: “PrivateAI’s overwhelming investor response and PGPT’s initial growth demonstrate a strong desire for AI applications that have a profound impact on science. We’re proud to be at the forefront of breakthroughs once deemed impossible.”
Building Bridges with Renowned Institutions
PrivateAI is actively establishing collaborations with leading longevity research communities across the globe. Discussions are underway with researchers at Oxford University, Versetti’s alma mater for his MSc in Evidence-Based Healthcare. Additionally, partnerships with Lifespan.io and Aging Research Drug Discovery (ARDD) further solidify PrivateAI’s commitment to fostering a global network of longevity research.
About PrivateAI
PrivateAI is a P2P (Peer-to-Peer) Data-as-a-Service (DaaS) network that provides a secure environment for data owners and consumers to connect. This platform empowers researchers and institutions to monetize their valuable datasets while enabling AI engineers and research facilities to access the data they need to drive scientific progress. The company’s leadership team boasts a proven track record of success, having achieved multiple exits in the web3 and AI sectors.
Join the Fight for a Longer Tomorrow
PrivateAI’s innovative approach to AI-powered longevity research presents a compelling vision for the future. With its strategic investment, token launch, and collaborative partnerships, PrivateAI is poised to make a significant impact on the field of longevity research.
Follow us on our social networks and keep up to date with everything that happens in the Metaverse!
Twitter Linkedin Facebook Telegram Instagram Google News Amazon Store